Endocrine-disorders

International Journal of Endocrinology: Published on February, 2023A recent study in the International Journal of Endocrinology (Feb 2023) found promising insights into thyroid disorder treatment, specifically evaluating Levothyroxine intake during Ramadan.Fasting during the month of Ramadan is an Islamic obligation and a great worship. Muslims...
The medication most used to treat hypothyroidism is levothyroxine, a compound that acts as a replacement for a person’s thyroid hormone. People with hypothyroidism will often need to take levothyroxine for a long time, typically for the rest of their life, so it is important that their treatment is monitored closely and the dose is adjusted fo...
Published on PubMed: October, 2022Endometriosis is a benign chronic inflammatory disease defined as the presence of endometrium outside of the uterine cavity. The disease affects 10% of women in reproductive age; it is mainly characterized by dysmenorrhea and infertility, affecting the quality of lifeDysmenorrhea, chronic pelvic pain, dyschezi...
PubMed Central: Published February, 2021Subclinical hypothyroidism (SCH) is a common biochemical entity identified in women during pregnancy. SCH is diagnosed when the thyroid stimulating hormone (TSH) is elevated with a normal free thyroxine (FT4) level. The thyroid hormone, FT4, is necessary for fetal growth and development. Insufficient thyr...
JAMA: The Journal of the American Medical Association: Published on November, 2022American Urological Association (AUA) and American Society for Reproductive Medicine (ASRM) provide an overview of current guidelines on the evaluation and treatment of male infertility and is an important tool for providers caring for these patients.With up to 20...
The Lancet Diabetes & Endocrinology: Published on February, 2023Metformin is increasingly being used during pregnancy, with potentially adverse long-term effects on children. This study aimed to examine adiposity in children of women with type 2 diabetes from the Metformin in Women with Type 2 Diabetes in Pregnancy (MiTy) trial, with and withou...
Diabetes Research and Clinical Practice: Published on December, 2022Sodium-Glucose Transport Protein 2 (SGLT2) Inhibitors also called gliflozins are a class of medicine used to lower high blood glucose levels in people with type 2 diabetes. Medicines in the SGLT2 inhibitor class include Canagliflozin, Dapagliflozin, Empagliflozin, Ertugli...
Clinical Diabetes and Endocrinology Journal: Published: May 2022Diabetes Mellitus (DM) is a debilitating metabolic disorder characterized by impaired insulin function, leading to chronic hyperglycemia.Diabetic nephropathy (DN) is one of the most common and severe microvascular complications of DM, occurring in about 20–30% of diabetic patients,...
The LANCET: Diabetes & Endocrinology: Published on July, 2022Diabetes is a major cause of death, cardiovascular complications, and health-care burden worldwide.People with type 2 diabetes who have high blood pressure are at an increased risk of morbidity and death from major cardiovascular events.However, there are inadequate randomised contro...
Diabetes, Obesity and Metabolism Journal: PubMedTAKE HOME MESSAGE:The study aims to investigate the effect of sequential treatment escalation with empagliflozin and linagliptin on laboratory markers of α- and β-cell function in people with type 2 diabetes mellitus (T2DM) insufficiently controlled on metformin monotherapy.The researchers found t...
Endometriosis can be asymptomatic; women often experience a range of symptoms with dysmenorrhea, non-menstrual pelvic pain (NMPP), and dyspareunia being more common; other symptoms include constipation, dyschezia, dysuria, and infertility. For many women, the burden of symptoms associated with endometriosis also reduces quality of life and profound...
AHA Journals: Hypertension: Published on May, 2022Diabetes is a strong risk factor for end-stage renal disease (ESRD). Hypertension also plays a crucial role in the development and progression of kidney failure. Blood pressure (BP) rises with declining kidney function which in turn aggravates hypertension. Moreover, as chronic kidney disease (C...